Company news
Starcoin Group Limited (HKEX:399) news
Starcoin Group Limited news releases on 6ix. Latest, Oct 2, 2026: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September…
Press releases & updates
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
EXTENSION OF LONG STOP DATE AMENDMENT TO THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS AND CONNECTED TRANSACTION AT SUBSIDIARY LEVEL AND CONTINUED SUSPENSION OF TRADING
September 30, 2026
QUARTERLY UPDATES ON THE IMPLEMENTATION OF ACTION PLANS TO RESOLVE THE DISCLAIMER OF OPINION AND CONTINED SUSPENSION OF TRADING
September 30, 2026
Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
May 5, 2026
Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
March 31, 2026
Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
March 25, 2026
Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
March 17, 2026
Starcoin Group, Newbridge And Conflux Foundation Entered MoU
March 10, 2026
Starcoin Group And Newbridge Enter MoU For De-Spac Deal
February 27, 2026
Starcoin Group Signs Strategic Cooperation Framework Agreement For RWA Tokenization Project
February 12, 2026
Starcoin Group Ltd To Uphold Decision To Suspend Trading In Company's Shares
February 2, 2026
Starcoin Says Co, Extrawell Pharmaceutical To Amend Amount Of Convertible Bonds To HK$1 Billion
December 2, 2025
Starcoin Says HY Revenue HK$3.2 Million
November 28, 2025
Starcoin Group Says Trading In Shares Will Continue
November 24, 2025
Starcoin Says Trading In Shares Will Be Suspended On 26 Nov
November 16, 2025
Starcoin Says Co Has Not Entered Into Any Merger And Acquisition Agreement With Tianxingjian
October 19, 2025
Starcoin Signed MoU For Genetic Epidemiology, Physiology Of Cardiovascular Disease & Its Risk Factors, Others
October 17, 2025
Starcoin Entered Into MoU With Starcoin Foundation
October 13, 2025